Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: A prospective assessment

Vincent W. Chiang, Jeffrey P. Burns, Nader Rifai, Steven E Lipshultz, M. Jacob Adams, Debra L. Weiner

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: To examine the cardiac toxicity as measured by elevations in serum cardiac troponin T (cTnT) and to compare creatine kinase (CK) and creatine kinase MB (CK-MB) and findings on electrocardiography (ECG) as markers of cardiac toxicity with cTnT during the infusion of intravenous terbutaline for the treatment of severe asthma in children. Study design: Prospective cohort study of patients receiving intravenous terbutaline for severe asthma. Results: Only 3 (10%) of the 29 patients had elevations in cTnT. Each underwent mechanical ventilation for >72 hours, which was the earliest point at which cTnT elevations were identified. Eighteen (62%) patients had an elevation in CK, and 3 had an elevation in CK-MB fraction without an elevated cTnT. Twenty (69%) patients had ECG findings consistent with ischemia, and 19 of these patients had the ischemic findings on their preterbutaline ECG. Elevations in CK and CK-MB and ischemic changes on ECG did not correlate with elevations in cTnT. Both mechanical ventilation (P = .02) and prolonged administration (>72 hours) of intravenous terbutaline (P = .02) were significantly associated with elevations in cTnT. Conclusions: We found no clinically significant cardiac toxicity from the use of intravenous terbutaline for severe asthma as measured by serum cTnT elevations.

Original languageEnglish
Pages (from-to)73-77
Number of pages5
JournalJournal of Pediatrics
Volume137
Issue number1
DOIs
StatePublished - Jul 1 2000
Externally publishedYes

Fingerprint

Terbutaline
Troponin T
Asthma
MB Form Creatine Kinase
Electrocardiography
Creatine Kinase
Therapeutics
Artificial Respiration
Cardiotoxicity
Serum
Intravenous Infusions
Cohort Studies
Ischemia
Prospective Studies

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children : A prospective assessment. / Chiang, Vincent W.; Burns, Jeffrey P.; Rifai, Nader; Lipshultz, Steven E; Adams, M. Jacob; Weiner, Debra L.

In: Journal of Pediatrics, Vol. 137, No. 1, 01.07.2000, p. 73-77.

Research output: Contribution to journalArticle

Chiang, Vincent W. ; Burns, Jeffrey P. ; Rifai, Nader ; Lipshultz, Steven E ; Adams, M. Jacob ; Weiner, Debra L. / Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children : A prospective assessment. In: Journal of Pediatrics. 2000 ; Vol. 137, No. 1. pp. 73-77.
@article{6547a784c5834555b5de9828977a134a,
title = "Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: A prospective assessment",
abstract = "Objective: To examine the cardiac toxicity as measured by elevations in serum cardiac troponin T (cTnT) and to compare creatine kinase (CK) and creatine kinase MB (CK-MB) and findings on electrocardiography (ECG) as markers of cardiac toxicity with cTnT during the infusion of intravenous terbutaline for the treatment of severe asthma in children. Study design: Prospective cohort study of patients receiving intravenous terbutaline for severe asthma. Results: Only 3 (10{\%}) of the 29 patients had elevations in cTnT. Each underwent mechanical ventilation for >72 hours, which was the earliest point at which cTnT elevations were identified. Eighteen (62{\%}) patients had an elevation in CK, and 3 had an elevation in CK-MB fraction without an elevated cTnT. Twenty (69{\%}) patients had ECG findings consistent with ischemia, and 19 of these patients had the ischemic findings on their preterbutaline ECG. Elevations in CK and CK-MB and ischemic changes on ECG did not correlate with elevations in cTnT. Both mechanical ventilation (P = .02) and prolonged administration (>72 hours) of intravenous terbutaline (P = .02) were significantly associated with elevations in cTnT. Conclusions: We found no clinically significant cardiac toxicity from the use of intravenous terbutaline for severe asthma as measured by serum cTnT elevations.",
author = "Chiang, {Vincent W.} and Burns, {Jeffrey P.} and Nader Rifai and Lipshultz, {Steven E} and Adams, {M. Jacob} and Weiner, {Debra L.}",
year = "2000",
month = "7",
day = "1",
doi = "10.1067/mpd.2000.106567",
language = "English",
volume = "137",
pages = "73--77",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children

T2 - A prospective assessment

AU - Chiang, Vincent W.

AU - Burns, Jeffrey P.

AU - Rifai, Nader

AU - Lipshultz, Steven E

AU - Adams, M. Jacob

AU - Weiner, Debra L.

PY - 2000/7/1

Y1 - 2000/7/1

N2 - Objective: To examine the cardiac toxicity as measured by elevations in serum cardiac troponin T (cTnT) and to compare creatine kinase (CK) and creatine kinase MB (CK-MB) and findings on electrocardiography (ECG) as markers of cardiac toxicity with cTnT during the infusion of intravenous terbutaline for the treatment of severe asthma in children. Study design: Prospective cohort study of patients receiving intravenous terbutaline for severe asthma. Results: Only 3 (10%) of the 29 patients had elevations in cTnT. Each underwent mechanical ventilation for >72 hours, which was the earliest point at which cTnT elevations were identified. Eighteen (62%) patients had an elevation in CK, and 3 had an elevation in CK-MB fraction without an elevated cTnT. Twenty (69%) patients had ECG findings consistent with ischemia, and 19 of these patients had the ischemic findings on their preterbutaline ECG. Elevations in CK and CK-MB and ischemic changes on ECG did not correlate with elevations in cTnT. Both mechanical ventilation (P = .02) and prolonged administration (>72 hours) of intravenous terbutaline (P = .02) were significantly associated with elevations in cTnT. Conclusions: We found no clinically significant cardiac toxicity from the use of intravenous terbutaline for severe asthma as measured by serum cTnT elevations.

AB - Objective: To examine the cardiac toxicity as measured by elevations in serum cardiac troponin T (cTnT) and to compare creatine kinase (CK) and creatine kinase MB (CK-MB) and findings on electrocardiography (ECG) as markers of cardiac toxicity with cTnT during the infusion of intravenous terbutaline for the treatment of severe asthma in children. Study design: Prospective cohort study of patients receiving intravenous terbutaline for severe asthma. Results: Only 3 (10%) of the 29 patients had elevations in cTnT. Each underwent mechanical ventilation for >72 hours, which was the earliest point at which cTnT elevations were identified. Eighteen (62%) patients had an elevation in CK, and 3 had an elevation in CK-MB fraction without an elevated cTnT. Twenty (69%) patients had ECG findings consistent with ischemia, and 19 of these patients had the ischemic findings on their preterbutaline ECG. Elevations in CK and CK-MB and ischemic changes on ECG did not correlate with elevations in cTnT. Both mechanical ventilation (P = .02) and prolonged administration (>72 hours) of intravenous terbutaline (P = .02) were significantly associated with elevations in cTnT. Conclusions: We found no clinically significant cardiac toxicity from the use of intravenous terbutaline for severe asthma as measured by serum cTnT elevations.

UR - http://www.scopus.com/inward/record.url?scp=0034234377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034234377&partnerID=8YFLogxK

U2 - 10.1067/mpd.2000.106567

DO - 10.1067/mpd.2000.106567

M3 - Article

C2 - 10891825

AN - SCOPUS:0034234377

VL - 137

SP - 73

EP - 77

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -